These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35919792)

  • 21. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups.
    Witting C; Zheng J; Tisdale RL; Shannon E; Kohsaka S; Lewis EF; Heidenreich P; Sandhu A
    JACC Heart Fail; 2023 Feb; 11(2):161-172. PubMed ID: 36647925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation.
    Stolfo D; Castrichini M; Biagini E; Compagnone M; De Luca A; Caiffa T; Berardini A; Vitrella G; Korcova R; Perkan A; Foroni M; Merlo M; Barbati G; Saia F; Rapezzi C; Sinagra G
    ESC Heart Fail; 2020 Aug; 7(4):1753-1763. PubMed ID: 32426906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Guideline-Directed Medical Therapy for Outpatients Living with Heart Failure with Reduced Ejection Fraction.
    McVannel T; Albers L; Kosar L; Reid B; Yeung C; Siddiqui M; Baran O
    Can J Hosp Pharm; 2024; 77(1):e3373. PubMed ID: 38482388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction.
    Wongsalap Y; Poolpun D; Keawhai K; Kitpluem N; Pansiri P; Malaimat S; Senthong V; Kengkla K
    Chronic Dis Transl Med; 2023 Jun; 9(2):154-163. PubMed ID: 37305111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
    Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
    Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction.
    Nauta JF; Santema BT; van der Wal MHL; Koops A; Warink-Riemersma J; van Dijk K; Inkelaar F; Prückl S; Suwijn J; van Deursen VM; Meijers WC; Coster J; Westenbrink BD; de Boer RA; Hummel Y; van Melle J; van Veldhuisen DJ; van der Meer P; Voors AA
    Neth Heart J; 2021 Jul; 29(7-8):383-393. PubMed ID: 34125353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP
    Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction.
    Barry AR; Grewal M; Blain L
    CJC Open; 2023 Apr; 5(4):303-309. PubMed ID: 37124968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
    Peri-Okonny PA; Mi X; Khariton Y; Patel KK; Thomas L; Fonarow GC; Sharma PP; Duffy CI; Albert NM; Butler J; Hernandez AF; McCague K; Williams FB; DeVore AD; Patterson JH; Spertus JA
    JACC Heart Fail; 2019 Apr; 7(4):350-358. PubMed ID: 30738978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Guideline-Directed Medical Therapy in Patients Aged ≥ 65 Years After the Diagnosis of Heart Failure: A Canadian Population-Based Study.
    Wahid M; Aghanya V; Sepehrvand N; Dover DC; Kaul P; Ezekowitz J
    CJC Open; 2022 Dec; 4(12):1015-1023. PubMed ID: 36562009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Malgie J; Wilde MI; Clephas PRD; Emans ME; Koudstaal S; Schaap J; Mosterd A; van Ramshorst J; Wardeh AJ; van Wijk S; van den Heuvel M; Wierda E; Borleffs CJW; Saraber C; Beeres SLMA; van Kimmenade R; Jansen Klomp W; Denham R; da Fonseca CA; Klip IT; Manintveld OC; van der Boon RMA; van Ofwegen CEE; Yilmaz A; Pisters R; Linssen GCM; Faber N; van Heerebeek L; van de Swaluw JEC; Bouhuijzen LJ; Post MC; Kuijper AFM; Wu KW; van Beek EA; Hesselink T; Kleijn L; Kurvers MJM; Tio RA; Langerveld J; van Dalen BM; van Eck JWM; Handoko ML; Hermans WRM; Koornstra-Wortel HJJ; Szymanski MK; Rooker D; Tandjung K; Eijsbouts SCM; Asselbergs FW; van der Meer P; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Eur J Heart Fail; 2024 Jul; 26(7):1549-1560. PubMed ID: 38734980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
    Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
    JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study.
    Khattab M; Parwani P; Abbas M; Ali H; Lozano PM; Thadani U; Dasari TW
    J Family Med Prim Care; 2020 Jun; 9(6):3065-3069. PubMed ID: 32984174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study.
    Kocabaş U; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir IH; Kaya E; Yüce EI; Avcı Demir F; Doğduş M; Altınsoy M; Üstündağ S; Özyurtlu F; Karagöz U; Karakuş A; Urgun ÖD; Sinan ÜY; Mutlu I; Şen T; Astarcıoğlu MA; Kınık M; Tok ÖÖ; Uygur B; Yeni M; Alan B; Dalgıç O; Sarıtürk Ç; Altay H; Pehlivanoğlu S
    Anatol J Cardiol; 2020 Jul; 24(1):32-40. PubMed ID: 32628147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug effects across patients with heart failure: a systematic review.
    Butzner M; Riello RJ; Sarocco P; Desai N
    Am J Manag Care; 2022 Mar; 28(3):e113-e120. PubMed ID: 35404555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure.
    Henrysson J; Thunström E; Chen X; Fu M; Basic C
    ESC Heart Fail; 2023 Feb; 10(1):66-79. PubMed ID: 36161782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.